tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cellectis Reports Q2 2025 Financials and Key Clinical Milestones
PremiumCompany AnnouncementsCellectis Reports Q2 2025 Financials and Key Clinical Milestones
28d ago
CLLS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CLLS Upcoming Earnings Report: What to Expect?
1M ago
Cellectis to Announce Q2 2025 Financial Results on August 4
Premium
Company Announcements
Cellectis to Announce Q2 2025 Financial Results on August 4
1M ago
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
PremiumRatingsCautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
4M ago
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
Premium
Ratings
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
4M ago
Cellectis price target lowered to $4 from $5 at Barclays
Premium
The Fly
Cellectis price target lowered to $4 from $5 at Barclays
4M ago
CLLS Earnings this Week: How Will it Perform?
PremiumPre-EarningsCLLS Earnings this Week: How Will it Perform?
4M ago
Cellectis Unveils Gene Editing Innovations at ASGCT Meeting
Premium
Company Announcements
Cellectis Unveils Gene Editing Innovations at ASGCT Meeting
4M ago
Cellectis S.A. Updates UCART Pipeline with Phase 2 Trial Details
Premium
Company Announcements
Cellectis S.A. Updates UCART Pipeline with Phase 2 Trial Details
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100